I think that we have to be very careful with evaluations of drugs intended for everyone. Our studies show that a drug is very effective for some patients, but less so for others. If the authorities decide that they are not going to make the drug available for that reason, the patients for whom it would be very effective will not have access to it. So we have to be very careful with evaluations that affect everyone rather than target groups.
On April 16th, 2007. See this statement in context.